Private Equity

Amid economic headwinds, the M&A advisor thrived by securing over 90 deals and promoting key partners, signaling strong momentum for healthcare sales in 2026.

KKR's landmark purchase of Cheongna Logistics Center, the largest in Korea, signals a massive bet on the nation's booming e-commerce infrastructure.

Peruvian financial giant Credicorp is buying Florida's Helm Bank, a strategic move to capture the lucrative cross-border wealth of Latin American clients.

The biopharma investment giant has now acquired 100% of the royalty stream for Roche's blockbuster SMA drug, a strategic move years in the making.

Just months after its IPO, Kandal M Venture is fighting to stay on Nasdaq. We explore the financial woes behind the stock's dramatic fall.

Influential advisory firm ISS backs Blue Ant's acquisition of Thunderbird, citing a 50% premium and boosting prospects for a Canadian media mega-merger.

After eliminating over $10.7M in debt, cannabis operator LEEF Brands leverages strong Q3 growth to fuel major expansion in California and New York.

After selling its Oklahoma assets, Amplify Energy has eliminated its debt and is now focusing its capital on high-potential Beta and Bairoil fields.

Kite Realty Group declared a special dividend for shareholders. We dig into whether this signals a healthy retail market or is simply a savvy tax strategy.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

After resolving a cease trade order, A.I.S. Resources is set to resume trading, putting its diverse gold and lithium projects back in the market spotlight.

SBA head Kelly Loeffler gives her 2025 pay to charity, a move that mixes disaster relief with support for controversial political group Turning Point USA.

Commodity giant Mercuria secures copper and gold from Pucobre's El Espino mine with a $375M financing deal, betting big on Chile and green metals.

Oncodesign Precision Medicine and Navigo Proteins end their radiotheranostics pact, shifting focus to internal programs amid high-stakes R&D challenges.

A historic $50M donation from Tom Golisano propels Arkansas Children's into a national alliance, tackling the state's critical child health crisis.

Beyond the grid, Xcel Energy invested over $14M and nearly 60,000 volunteer hours, strategically fueling local economies and its own green future.

A strategic acquisition, backed by Argonne Capital, sets the stage for major expansion in Texas's booming specialized lighting and holiday décor market.

The Danish firm scraps its 2025 revenue forecast, accepting a larger loss in a bold move to secure more lucrative future deals for its key drug candidates.

The premier investor summit returns with a global tour, new sessions on real estate, and a renewed focus on funding critical pediatric cancer research.

Formerly Nature Wood Group, the forestry firm reports a surprise profit despite falling revenue after a complete change in ownership and leadership.